Developer docs
API playgroundTry for free, no card

Search company profiles

HeraMED

Full company profile

uuid0005ye3

Namestring
HeraMED
Legal namestring
Hera Med Ltd.
Websiteurl
hera-med.com
Company typeenum
Public
Founded yearint
2011
Descriptiontext

HeraMED is an ASX-listed (HMD) digital health company that develops and sells an AI-powered platform for women's healthcare spanning fertility, pregnancy, postpartum, menopause, and chronic care. Its core offering combines the FDA-cleared HeraBEAT fetal heart rate monitor with the HeraCARE software platform, which integrates remote patient monitoring, embedded telehealth with ambient scribing, an AI Clinician Dashboard, and an AI Patient Engagement App driven by a Virtual Companion trained in women's health. The company primarily serves large healthcare systems, hospital networks, and women's health clinicians on a B2B basis, with active deployments at named institutions including Broward Health, Lee Health, Sheba Medical Center, Joondalup Health Campus, Gold Coast Hospital, and Telstra Health, as well as a partnership with Philips to bring a maternity solution to the US market.

HeraMED's business model rests on three revenue streams: enterprise SaaS subscriptions for the HeraCARE platform (multi-year contracts such as a 2-year Broward Health agreement and a 3-year e-Lovu agreement), hardware sales of the HeraBEAT device, and professional services tied to pilot deployments and clinical trials. Its go-to-market blends direct enterprise field sales to large hospital networks with channel partnerships (Telstra Health for Australia, Philips for the US, Garmin Health for wearable data integration, Founda Health for European exploration, GPEx for regional distribution). The motion is characteristically enterprise health-tech: paid pilots convert into multi-year commercial agreements over extended sales cycles.

Founded in 2011, HeraMED is headquartered in Netanya, Israel, with US operations in Tustin, California, and an Australian headquarters in Hawthorn East, Victoria. The company operates with 11-50 employees and has raised approximately AUD 22 million across multiple placements and a convertible note since 2021, indicating it remains cash-consumption negative and dependent on recurring equity capital to fund US expansion and its next-generation AI roadmap.

Short descriptiontext

HeraMED is an ASX-listed digital health company offering the AI-powered HeraCARE platform and FDA-cleared HeraBEAT fetal monitor. It serves hospitals and healthcare systems via subscription SaaS, remote monitoring, telehealth, and AI-driven clinical and patient engagement tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote pregnancy monitoring, digital maternity care, AI women's health, fetal heart rate monitoring, maternal health platform
Industry4 codes
PRIMARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Home Health Care Services621610
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Prepackaged Software7372
Product category
Digital Maternity / Women's Health SaaS
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS/Software Platform Subscription
TypeSubscription Recurring
Description

Subscription-based SaaS model for healthcare organizations accessing the HeraCARE platform. Healthcare providers pay recurring fees for access to the AI-powered women's health platform, remote monitoring, and clinician tools. Multi-year agreements with health systems suggest enterprise subscription pricing.

hera-med.com
2Hardware Sales (HeraBEAT)
TypeHardware Sales
Description

Sale of FDA-cleared fetal monitoring devices (HeraBEAT) to healthcare providers and potentially directly to consumers for home monitoring.

hera-med.com
3Professional Services
TypeProfessional Services
Description

Implementation and training services for healthcare organization deployment. Pilot programs and clinical trial partnerships generate service revenue.

hera-med.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise healthcare organizations (hospitals, health systems)
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based pricing for multi-year enterprise agreements with healthcare systems. No public pricing available.

hera-med.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1HeraBEAT
Description

FDA-cleared fetal heart rate monitor device with upgraded TGA regulatory classification

markets.financialcontent.com
+2 more records
Core offering1 text field

HeraMED develops and sells the HeraCARE digital health platform, an AI-powered, SaaS-based solution for women's health spanning fertility, pregnancy, postpartum, menopause, and chronic care. It combines remote monitoring, embedded telehealth, AI-driven patient engagement (virtual companion), and an AI clinician dashboard with ambient scribing, paired with the FDA-cleared HeraBEAT fetal heart rate monitor for home and clinical use. The offering is delivered as enterprise subscriptions to hospitals, health systems, and channel partners such as Telstra Health and Philips.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 50% lower postpartum readmissions
+5 more records
Product overview1 text field

HeraMED offers an intelligent digital health platform for women combining AI-powered clinical tools, an empathetic Virtual Companion, and remote monitoring capabilities. The core HeraCARE Platform spans women's life stages from fertility through pregnancy, postpartum, menopause, and chronic care. Key products include the FDA-cleared HeraBEAT fetal monitor for home-based prenatal monitoring, the AI Clinician Dashboard with ambient scribing for automated clinical documentation, the AI Patient Engagement App with a Virtual Companion for personalized patient support, and integrated telehealth functionality. The platform delivers 50% lower postpartum readmissions, 50% fewer in-person visits, and hypertension detection at 25 weeks or earlier.

Product and service2 records
1HeraCARE Platform
CategoryDigital Women's Health SaaS Platform
Description

AI-powered, SaaS digital health platform for women's health spanning fertility, pregnancy, postpartum, menopause, and chronic care, combining remote monitoring, embedded telehealth, AI-driven patient engagement, and a clinician dashboard with ambient scribing; sold as multi-year enterprise subscriptions to hospital networks and health systems such as Broward Health, Lee Health, Sheba Medical Center, and Joondalup Health Campus.

2HeraBEAT
CategoryConnected Medical Device
Description

FDA-cleared fetal heart rate monitor providing medical-grade remote prenatal monitoring for use at home and in clinical settings; receives TGA regulatory classification upgrade in Australia. Distributed through hospital deployments and channel partners such as Philips and Telstra Health.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-27
Description

HeraMED partnered with Lee Health for a digital maternity solution. Lee Health is one of the largest public health systems in the US, representing significant market access for HeraMED's platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-25
Description

Heramed partnered with Philips to develop a US maternity solution. This is a significant strategic partnership with a global leader in healthcare technology for maternity care deployment in the US market.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-06-16
Description

Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC (Digital Health Cooperative Research Centre) (Jun 2025). Academic research partnership.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-25
Description

Strategic Collaboration Agreement with Garmin Health (Feb 2025). Integration of wearable device data into HeraCARE platform for enhanced monitoring capabilities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-26
Description

LOI with Metronomic to develop postpartum care solution in US (Nov 2024). Metronomic focuses on chronic disease management.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-09-23
Description

Letter of Intent with Founda Health to explore European market expansion. Founda Health provides digital health infrastructure in Europe.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-07-15
Description

UTS Strategic Partnership announced (Jul 2024). Academic partnership for research and development in women's health technology.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-16
Description

Strategic collaboration and commercial agreement with GPEx (Jan 2024). GPEx is an Australian health technology distributor.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-12-19
Description

USA-based Wingwomen signs MoU to launch 'Cardio Care' (Dec 2023). Women's health-focused company.

10FemBridge
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-12-18
Description

MOU signed with US-based FemBridge for maternity care solution (Dec 2023). Binding Strategic Partnership Agreement signed (Mar 2024).

hera-med.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-21
Description

Signed Partner Agreement with Telstra Health (Nov 2023). Telstra Health soft launched HeraCARE (Jun 2024). Telstra Health is a major Australian health technology company providing digital health solutions.

12e-Lovu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-28
Description

HMD & e-Lovu Health Partnership for HeraCARE Deployment US (Jul 2022). E-Lovu signs first 3-year commercial agreement (Jun 2023). Successful first phase commercial rollout (Feb 2023).

hera-med.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based maternal health platform offering remote pregnancy monitoring and patient engagement for health systems. Closely comparable to HeraCARE on the pregnancy-monitoring use case, B2B health-system GTM, and outcomes-driven value proposition.

TypeDirect peer
Description

Digital women's health platform covering fertility, pregnancy and postpartum, now owned by Labcorp. Comparable as an AI-enabled, life-stage-spanning women's health platform sold into payers and employers.

TypeDirect peer
Description

Virtual care clinic for women and families spanning fertility, maternity, postpartum and pediatrics. Directly comparable in B2B payer/employer GTM and life-stage breadth to HeraMED's HeraCARE scope.

TypeDirect peer
Description

Enterprise women's health platform sold to health plans and providers for maternity and family health journeys. Comparable to HeraMED's payer/provider B2B motion and life-stage patient-engagement focus.

TypeDirect peer
Description

Maternal and infant health platform providing pregnancy and postpartum support via care coordination and telehealth. Comparable as a maternal-health-focused digital health company with health-system partnerships.

TypeDirect peer
Description

AI-powered pregnancy care platform for providers and payers, focused on remote monitoring and risk detection. Comparable to HeraCARE on AI-driven maternal monitoring, B2B health-plan GTM, and outcomes analytics.

TypeEmerging player
Description

Benefits management platform focused on fertility, women's reproductive health and family building for employers. Comparable in women's health life-stage coverage and B2B employer/plan channel, though narrower scope (no pregnancy monitoring).

TypeEmerging player
Description

Pioneering RNA-based early detection of pregnancy complications. Comparable as a pregnancy-health technology company pursuing clinical evidence and provider partnerships in the same maternal care category.

TypeBroad incumbent
Description

Global healthcare technology incumbent with a maternal and fetal monitoring portfolio and a co-development partner of HeraMED for US maternity. Comparable as both a potential competitor and incumbent buyer/partner with deeper US hospital reach.

TypeBroad incumbent
Description

Large virtual care incumbent operating across primary care, chronic conditions and specialty telehealth for employers and health plans. Comparable as a broader incumbent that could bundle women's health into enterprise contracts HeraMED also targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HeraMED

Digital Maternity / Women's Health SaaShera-med.com

HeraMED is an ASX-listed digital health company offering the AI-powered HeraCARE platform and FDA-cleared HeraBEAT fetal monitor. It serves hospitals and healthcare systems via subscription SaaS, remote monitoring, telehealth, and AI-driven clinical and patient engagement tools.

What HeraMED does

HeraMED is an ASX-listed (HMD) digital health company that develops and sells an AI-powered platform for women's healthcare spanning fertility, pregnancy, postpartum, menopause, and chronic care. Its core offering combines the FDA-cleared HeraBEAT fetal heart rate monitor with the HeraCARE software platform, which integrates remote patient monitoring, embedded telehealth with ambient scribing, an AI Clinician Dashboard, and an AI Patient Engagement App driven by a Virtual Companion trained in women's health. The company primarily serves large healthcare systems, hospital networks, and women's health clinicians on a B2B basis, with active deployments at named institutions including Broward Health, Lee Health, Sheba Medical Center, Joondalup Health Campus, Gold Coast Hospital, and Telstra Health, as well as a partnership with Philips to bring a maternity solution to the US market.

HeraMED's business model rests on three revenue streams: enterprise SaaS subscriptions for the HeraCARE platform (multi-year contracts such as a 2-year Broward Health agreement and a 3-year e-Lovu agreement), hardware sales of the HeraBEAT device, and professional services tied to pilot deployments and clinical trials. Its go-to-market blends direct enterprise field sales to large hospital networks with channel partnerships (Telstra Health for Australia, Philips for the US, Garmin Health for wearable data integration, Founda Health for European exploration, GPEx for regional distribution). The motion is characteristically enterprise health-tech: paid pilots convert into multi-year commercial agreements over extended sales cycles.

Founded in 2011, HeraMED is headquartered in Netanya, Israel, with US operations in Tustin, California, and an Australian headquarters in Hawthorn East, Victoria. The company operates with 11-50 employees and has raised approximately AUD 22 million across multiple placements and a convertible note since 2021, indicating it remains cash-consumption negative and dependent on recurring equity capital to fund US expansion and its next-generation AI roadmap.

HeraMED firmographics

Firmographics
Name
HeraMED
Legal name
Hera Med Ltd.
Website
https://hera-med.com
Company type
Public
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
HeraMED is an ASX-listed digital health company offering the AI-powered HeraCARE platform and FDA-cleared HeraBEAT fetal monitor. It serves hospitals and healthcare systems via subscription SaaS, remote monitoring, telehealth, and AI-driven clinical and patient engagement tools.
Ownership category
akta.pro rank

HeraMED industry classification

Industry
Product category
Digital Maternity / Women's Health SaaS
NAICS
Home Health Care Services (621610), Custom Computer Programming Services (541511)
SIC
Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Remote pregnancy monitoring
  • Digital maternity care
  • AI women's health
  • Fetal heart rate monitoring
  • Maternal health platform

Where HeraMED is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

HeraMED business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS/Software Platform Subscription: Subscription-based SaaS model for healthcare organizations accessing the HeraCARE platform. Healthcare providers pay recurring fees for access to the AI-powered women's health platform, remote monitoring, and clinician tools. Multi-year agreements with health systems suggest enterprise subscription pricing.
  2. Hardware Sales (HeraBEAT): Sale of FDA-cleared fetal monitoring devices (HeraBEAT) to healthcare providers and potentially directly to consumers for home monitoring.
  3. Professional Services: Implementation and training services for healthcare organization deployment. Pilot programs and clinical trial partnerships generate service revenue.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise healthcare organizations (hospitals, health systems)

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

HeraMED product offering

Product offering

Core offering

HeraMED develops and sells the HeraCARE digital health platform, an AI-powered, SaaS-based solution for women's health spanning fertility, pregnancy, postpartum, menopause, and chronic care. It combines remote monitoring, embedded telehealth, AI-driven patient engagement (virtual companion), and an AI clinician dashboard with ambient scribing, paired with the FDA-cleared HeraBEAT fetal heart rate monitor for home and clinical use. The offering is delivered as enterprise subscriptions to hospitals, health systems, and channel partners such as Telstra Health and Philips.

Product overview

HeraMED offers an intelligent digital health platform for women combining AI-powered clinical tools, an empathetic Virtual Companion, and remote monitoring capabilities. The core HeraCARE Platform spans women's life stages from fertility through pregnancy, postpartum, menopause, and chronic care. Key products include the FDA-cleared HeraBEAT fetal monitor for home-based prenatal monitoring, the AI Clinician Dashboard with ambient scribing for automated clinical documentation, the AI Patient Engagement App with a Virtual Companion for personalized patient support, and integrated telehealth functionality. The platform delivers 50% lower postpartum readmissions, 50% fewer in-person visits, and hypertension detection at 25 weeks or earlier.

Differentiator

Problem solved

Functional benefit

Brands

  • HeraBEAT: FDA-cleared fetal heart rate monitor device with upgraded TGA regulatory classification
  • HeraCARE
  • e-Lovu

Products and services

  • HeraCARE Platform AI-powered, SaaS digital health platform for women's health spanning fertility, pregnancy, postpartum, menopause, and chronic care, combining remote monitoring, embedded telehealth, AI-driven patient engagement, and a clinician dashboard with ambient scribing; sold as multi-year enterprise subscriptions to hospital networks and health systems such as Broward Health, Lee Health, Sheba Medical Center, and Joondalup Health Campus.
  • HeraBEAT FDA-cleared fetal heart rate monitor providing medical-grade remote prenatal monitoring for use at home and in clinical settings; receives TGA regulatory classification upgrade in Australia. Distributed through hospital deployments and channel partners such as Philips and Telstra Health.

Quantifiable outcome

  • 50% lower postpartum readmissions
  • +5 more outcomes

Companies that use HeraMED

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

HeraMED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

HeraMED partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • Lee HealthcoreStrategic or Co-development Partner · 27 November 2025HeraMED partnered with Lee Health for a digital maternity solution. Lee Health is one of the largest public health systems in the US, representing significant market access for HeraMED's platform.
  • Philips (Koninklijke Philips N.V.)coreChannel Partner/ Reseller/ Distributor · 25 November 2025Heramed partnered with Philips to develop a US maternity solution. This is a significant strategic partnership with a global leader in healthcare technology for maternity care deployment in the US market.
  • RMIT UniversityminorStrategic or Co-development Partner · 16 June 2025Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC (Digital Health Cooperative Research Centre) (Jun 2025). Academic research partnership.
  • Garmin HealthcoreTechnology or Integration · 25 February 2025Strategic Collaboration Agreement with Garmin Health (Feb 2025). Integration of wearable device data into HeraCARE platform for enhanced monitoring capabilities.
  • MetronomicminorStrategic or Co-development Partner · 26 November 2024LOI with Metronomic to develop postpartum care solution in US (Nov 2024). Metronomic focuses on chronic disease management.
  • Founda HealthminorStrategic or Co-development Partner · 23 September 2024Letter of Intent with Founda Health to explore European market expansion. Founda Health provides digital health infrastructure in Europe.
  • University of Technology Sydney (UTS)minorStrategic or Co-development Partner · 15 July 2024UTS Strategic Partnership announced (Jul 2024). Academic partnership for research and development in women's health technology.
  • GPExminorChannel Partner/ Reseller/ Distributor · 16 January 2024Strategic collaboration and commercial agreement with GPEx (Jan 2024). GPEx is an Australian health technology distributor.
  • WingwomenminorStrategic or Co-development Partner · 19 December 2023USA-based Wingwomen signs MoU to launch 'Cardio Care' (Dec 2023). Women's health-focused company.
  • FemBridgeminorStrategic or Co-development Partner · 18 December 2023MOU signed with US-based FemBridge for maternity care solution (Dec 2023). Binding Strategic Partnership Agreement signed (Mar 2024).
  • Telstra HealthcoreChannel Partner/ Reseller/ Distributor · 21 November 2023Signed Partner Agreement with Telstra Health (Nov 2023). Telstra Health soft launched HeraCARE (Jun 2024). Telstra Health is a major Australian health technology company providing digital health solutions.
  • e-LovucoreStrategic or Co-development Partner · 28 July 2022HMD & e-Lovu Health Partnership for HeraCARE Deployment US (Jul 2022). E-Lovu signs first 3-year commercial agreement (Jun 2023). Successful first phase commercial rollout (Feb 2023).

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

HeraMED competitors and assessment

Company assessment

Direct peers

  • Babyscripts: US-based maternal health platform offering remote pregnancy monitoring and patient engagement for health systems. Closely comparable to HeraCARE on the pregnancy-monitoring use case, B2B health-system GTM, and outcomes-driven value proposition.
  • Ovia Health (by Labcorp): Digital women's health platform covering fertility, pregnancy and postpartum, now owned by Labcorp. Comparable as an AI-enabled, life-stage-spanning women's health platform sold into payers and employers.
  • Maven Clinic: Virtual care clinic for women and families spanning fertility, maternity, postpartum and pediatrics. Directly comparable in B2B payer/employer GTM and life-stage breadth to HeraMED's HeraCARE scope.
  • Wildflower Health: Enterprise women's health platform sold to health plans and providers for maternity and family health journeys. Comparable to HeraMED's payer/provider B2B motion and life-stage patient-engagement focus.
  • Mahmee: Maternal and infant health platform providing pregnancy and postpartum support via care coordination and telehealth. Comparable as a maternal-health-focused digital health company with health-system partnerships.
  • Delfina Care: AI-powered pregnancy care platform for providers and payers, focused on remote monitoring and risk detection. Comparable to HeraCARE on AI-driven maternal monitoring, B2B health-plan GTM, and outcomes analytics.

Emerging players

  • Progyny: Benefits management platform focused on fertility, women's reproductive health and family building for employers. Comparable in women's health life-stage coverage and B2B employer/plan channel, though narrower scope (no pregnancy monitoring).
  • Mirvie: Pioneering RNA-based early detection of pregnancy complications. Comparable as a pregnancy-health technology company pursuing clinical evidence and provider partnerships in the same maternal care category.

Broad incumbents

  • Philips (maternal health division): Global healthcare technology incumbent with a maternal and fetal monitoring portfolio and a co-development partner of HeraMED for US maternity. Comparable as both a potential competitor and incumbent buyer/partner with deeper US hospital reach.
  • Teladoc Health: Large virtual care incumbent operating across primary care, chronic conditions and specialty telehealth for employers and health plans. Comparable as a broader incumbent that could bundle women's health into enterprise contracts HeraMED also targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

HeraMED social profiles

Digital presence

HeraMED compliance and trust

Trust signal

Compliance2 records

HeraMED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HeraMED leadership team

Management profile

Number of profiles

Profiles11 records

HeraMED funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HeraMED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeraMED

What does HeraMED do?

HeraMED develops and sells the HeraCARE digital health platform, an AI-powered, SaaS-based solution for women's health spanning fertility, pregnancy, postpartum, menopause, and chronic care. It combines remote monitoring, embedded telehealth, AI-driven patient engagement (virtual companion), and an AI clinician dashboard with ambient scribing, paired with the FDA-cleared HeraBEAT fetal heart rate monitor for home and clinical use. The offering is delivered as enterprise subscriptions to hospitals, health systems, and channel partners such as Telstra Health and Philips.

Is HeraMED a public or private company?

HeraMED is a public company. It is classified as public and is currently operating.

When was HeraMED founded?

HeraMED was founded in 2011. It employs 11 to 50 people.

Where is HeraMED based?

HeraMED is headquartered in Melbourne, Australia, in the Oceania region.

How does HeraMED make money?

Three revenue lines are on record. SaaS/Software Platform Subscription is the primary driver. The others are hardware Sales (HeraBEAT) and professional Services.

Who are HeraMED's main competitors?

Direct peers on record are Babyscripts, Ovia Health (by Labcorp), Maven Clinic, Wildflower Health, Mahmee and Delfina Care. Emerging players are Progyny and Mirvie. Broad incumbents are Philips (maternal health division) and Teladoc Health.

Does HeraMED have an API?

No public API is recorded for HeraMED.

What industry is HeraMED in?

HeraMED's product category is Digital Maternity / Women's Health SaaS. Its primary akta.pro industry code is HLALAHAC, Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring), with a secondary code of HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated). Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
THE STANDARDข้อมูลบนข้อมือ ช่วยดูแลสุขภาพเราได้แค่ไหน?Garmin Health Summit 2026 was held in Thailand, featuring panelists on longevity, AI, and mind-body research. The event announced Garmin Health Awards 2026 winners: Montefiore Einstein for using wearable data to predict treatment complications, and HeraMED for AI-based women's health care.Nate가민 헬스 어워즈 2026, 여성 건강·암 치료 분야 웨어러블 활용 팀 수상 : 네이트 뉴스HeraMED and Montefiore Einstein won the People's Choice and Expert's Choice awards at the 2026 Garmin Health Awards in Bangkok. Each team received a $10,000 Garmin smartwatch and fitness tracker. The awards recognized wearable-based digital health innovations across insurance, oncology, and wellness.StockheadHeraMED signs paid pilot with Obstetrix Medical Group, providers of care and diagnostics to 1 in 4 babies born in USMedtech company HeraMED has signed a paid pilot agreement with Obstetrix Medical Group to deploy its HeraCARE pregnancy monitoring platform for 100 expectant mothers in the US. The pilot serves as a precursor to a potential comprehensive commercial agreement, marking HeraMED's significant entry into the US market via a SaaS-based model. This development follows recent positive market reactions and builds on HeraMED's existing partnerships in Australia and connections with major healthcare institutions.